Advantages of Conducting a Stand-Alone Respiratory Safety Pharmacology Study - PowerPoint PPT Presentation

1 / 3
About This Presentation
Title:

Advantages of Conducting a Stand-Alone Respiratory Safety Pharmacology Study

Description:

Advantages of Conducting a Stand-Alone Respiratory Safety Pharmacology Study Dennis J. Murphy, PhD, DABT Director - Safety Pharmacology US GlaxoSmithKline Pharmaceuticals – PowerPoint PPT presentation

Number of Views:54
Avg rating:3.0/5.0
Slides: 4
Provided by: Cham167
Category:

less

Transcript and Presenter's Notes

Title: Advantages of Conducting a Stand-Alone Respiratory Safety Pharmacology Study


1
Advantages of Conducting a Stand-Alone
Respiratory Safety Pharmacology Study
  • Dennis J. Murphy, PhD, DABT
  • Director - Safety Pharmacology US
  • GlaxoSmithKline Pharmaceuticals

2
Advantages
  • Ventilatory measurements in animal models can be
    highly variable due primarily to a sensitivity to
    environmental changes (stimuli)
  • Stimuli include noise, odor, movement, handling,
    light, temperature
  • As such, measurements require a highly controlled
    environment for accurate and repeatable
    measurements
  • This can be achieved in a stand-alone study
  • Very difficult to achieve in a typical toxicology
    study where many activities are constantly
    ongoing and high number of animals are involved
  • Stand-alone studies allow the use of animals with
    a telemetry implant for measuring body
    temperature and pleural pressure (required to
    obtain a direct measure of airway resistance)
  • Generally not acceptable in a toxicology study
    due to pathology complications and resource
    limitations

3
Advantages (continued)
  • Stand-alone studies have greater flexibility in
    study design
  • Can use either crossover designs (animals serve
    as their own control) or parallel design with n
    6-8 of single sex per dose group
  • Can include recovery time for assessing
    reversibility or delayed effects (beyond 24 hrs
    post dose)
  • A typical 2/4 week toxicology study can be
    limited to a parallel design with n3/sex per
    dose group (non-rodent) (sufficient for
    statistical analysis?) and may not include a
    recovery period (rodent or non-rodent)
  • Acute (day 1) measurements can be obtained with
    stand-alone studies
  • Day 1 measurements are critical because of
    tachyphylaxis or tolerance/compensation that can
    develop on repeat dosing
  • This can be difficult in toxicology studies
    because of TK analysis and enhanced clinical
    observations that need to be conducted on day1
Write a Comment
User Comments (0)
About PowerShow.com